2022. Deferasirox on COVID-19: safety and efficacy of iron-chelating therapy. A multicentric, randomized, triple blinded study. Principles and Practice of Clinical Research. 7, 4 (Jan. 2022), 38–46. DOI:https://doi.org/10.21801/ppcrj.2021.74.5.